Private, Secure and 100% Trusted

Medical reports
invalid valid
I have read and agree to the Terms & Conditions and Privacy Policy
loading
Saving...
Saved

Ask Dr Sonali Ashok Sadawarte for Second Opinion

Dr Sonali Ashok Sadawarte | Second Opinion | BestDoctor

Dr Sonali Ashok Sadawarte

( MBBS, MD, DM, FRACP )

Hematologist

  • Medical Officer at Padhar Mission Hospital, Padhar, Madhya Pradesh from 1999 - 2001
  • Resident (Internal Medicine) at Mahatma Gandhi Institute of Medical Sciences, Mumbai from 2001 - 2003
  • Registrar (ICU) at Bombay Hospital Institute of Medical Sciences, Mumbai from 2004 - 2005
  • Lecturer (Internal Medicine) at BYL Nair Hospital, Mumbai from Apr 2005 - Jul 2005
  • Registrar (Hematology) at Seth GS Medical College and KEM Hospital, Mumbai from 2005 - 2008
  • Registrar (Transfusion Medicine, Hematology) at Monash Medical Centre Clayton and Australian Red Cross Blood Services (ARCBS), Melbourne, Australia from 2009 - 2010
  • Leukaemia Research Fellow at The Alfred Hospital, Melbourne, Australia from 2010 - 2011
  • Senior Registrar (Clinical Hematology) at Royal Hobart Hospital, Tasmania, Australia from 2011 - 2012
  • Clinical Hematologist at Royal Hobart Hospital, Tasmania, Australia
  • MBBS from Mahatma Gandhi Institute of Medical Sciences, Wardha, Maharashtra in 1997
  • MD (Internal Medicine) from Mahatma Gandhi Institute of Medical Sciences, Wardha, Maharashtra in 2003
  • DM (Hematology) from King Edward Memorial Hospital, Mumbai in 2008
  • Fellow of Royal Australian College of Physicians (FRACP) in Hematology in 2012
  • Assessment of response to injectable vitamin B12 and folic acid in patients of macrocytic anaemia at Mahatma Gandhi Institute of Medical Sciences, Maharashtra
  • A study of Paroxysmal Nocturnal Hemoglobinuria from a tertiary centre in Western India.
  • Actively involved in the multicentric trial of upfront Arsenic Trioxide in patients of APML at KEM Hospital, Mumbai
  • Active clinical research in malignant hematology working as a Leukaemia Research Fellow at The Alfred Hospital. This involved being a sub investigator for 10-12 clinical trials which were investigator initiated (Phase 1-2) as well as multicentric international trials (phase 3).
  • At Royal Hobart Hospital, the research activities included being a sub investigator in about 6-7 (phase 2-3) clinical trials and Principal Investigator for 2 ALLG trials (Phase 1, 2 and 3).
  • Platelet rise as an earliest response to vitamin B12 and folic acid therapy in macrocytic anemia - Journal of MGIMS 2003
  • An unusual presentation of Pediatric Acute Lymphoblastic Leukemia - Pediatric Blood and Cancer 2007; 49(4).
  • An unusual presentation of childhood Acute Lymphoblastic Leukemia - Indian Journal of Hematology and Blood Transfusion; 24(2): 59-62
  • A study of PNH from tertiary centre in Western India - Indian Journal of Hematology and Blood Transfusion 2008; 24(3): 86-145
  • Sadawarte S, Patil S, Muirhead J, Spencer A, Avery S, Walker P, Das T and Wei A. Outpatient based non-myeloablative stem cell transplant for older patients with AML in 1st remission - Poster presentation and publication in The Alfred Research Week Journal, 2010
  • A study of PNH from tertiary centre in Western India - Annual conference of Indian Society of Hematology and Transfusion Medicine, JIPMER, Pondicherry 2008
  • Wei A, Sadawarte S, Patil S, Muirhead J, Spencer A, Avery S, Walker P, Das T. Outpatient based non-myeloablative stem cell transplant for older patients with AML in 1st remission. 2010
Pending draft ... Click to resume editing
Discard draft